Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study

BACKGROUND: The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and a potential benefit of anticoagulation therapy has been documented for prevention of thromboembolic events. Bleeding events has also been reported as a notable complication; whereas, the incidence, risks, and clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Junichi, Tsujino, Ichizo, Yachi, Sen, Takeyama, Makoto, Nishimoto, Yuji, Konno, Satoshi, Yamamoto, Naoto, Nakata, Hiroko, Ikeda, Satoshi, Umetsu, Michihisa, Aikawa, Shizu, Hayashi, Hiroya, Satokawa, Hirono, Okuno, Yoshinori, Iwata, Eriko, Ogihara, Yoshito, Ikeda, Nobutaka, Kondo, Akane, Iwai, Takehisa, Yamada, Norikazu, Ogawa, Tomohiro, Kobayashi, Takao, Mo, Makoto, Yamashita, Yugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485792/
https://www.ncbi.nlm.nih.gov/pubmed/36127738
http://dx.doi.org/10.1186/s12959-022-00414-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485792/
https://www.ncbi.nlm.nih.gov/pubmed/36127738
http://dx.doi.org/10.1186/s12959-022-00414-x

Ejemplares similares